Challenges Of Iranian Clinicians In Dealing With COVID-19: Taking Advantages Of The Experiences In Wenzhou

• Main Authors: Yaser Tahamtani, Mehdi Totonchi, Chengshui Chen, Seyed Mohammad Reza Hashemian, Fatemeh Amoozegar, Jin-San Zhang, Yousef Gholampour, Xiaokun Li
• Format: Article
• Language: English
• Published: Royan Institute (ACECR), Tehran 2020-09-01
• Series: Cell Journal
• Subjects: anti-inflammatory drug; antiviral drug; covid-19; diagnosis; sars-cov-2
• Online Access: https://celljournal.org/journal/article/fulltext/challenges-of-iranian-clinicians-in-dealing-with-covid-19-taking-advantages-of-the-experiences-in-wenzhou.pdf
• ISSN: 2228-5806; 2228-5814

The novel coronavirus has been spreading since December 2019. It was initially reported in Wuhan, Hubei province of China. Coronavirus disease 2019 (COVID-19) has currently become a pandemic affecting over seven million people worldwide, and the number is still rising. Wenzhou, as the first hit city out of Hubei Province, achieved a remarkable success in effectively containing the disease. A great record was also observed in Wenzhou for the clinical management of COVID-19 patients, leading to one of the lowest death rates in China. Researchers and clinical specialists proposed and formulated combined approaches such as computerized tomography (CT)- scans and molecular assays, as well as using both allopathic and traditional medications to mitigate its effects. Iranian and Chinese specialists and scientists had a communication in clinical, molecular and pharmaceutical aspects of COVID-19. A proper guideline was prepared according to the experiences of Chinese clinicians in managing the full spectrum of COVID-19 patients, from relatively mild to highly complex cases. The purpose of this guideline is to serve a reference in the hospital for specialists so that they may better diagnose cases and provide effective therapies and proposed antiviral and anti-inflammatory drugs for patients.